The guideline development process - an overview for stakeholders, the public and the NHS
This document describes the process used to develop clinical guidelines up to March 2006. It has been replaced by a new edition (published in 2006): The guidelines manual - Appendix L: The guideline development process. However, some guidelines that were at a late stage of development in April 2006 are being produced by the process described in the 2004 edition.
![]() |
The guideline development process - an overview for stakeholders, the public and the NHS
07 May 2004 (0 b) |
This page was last updated: 30 March 2010
-
CG71 Familial hypercholesterolaemia: review proposal (PDF 282 KB)
-
Familial hypercholesterolaemia: review decision (PDF 153 KB)
-
Familial hypercholesterolaemia: draft consultation comments 1 (PDF 255 KB)
-
Familial hypercholesterolaemia: draft consultation comments 2 (PDF 264 KB)
-
-
Familial hypercholesterolaemia: GDG minutes 23 June 2008 (PDF 70 KB)
-
Familial hypercholesterolaemia: GDG minutes 2 May 2008 (PDF 76 KB)
-
Familial hypercholesterolaemia: GDG minutes 11 January 2008 (PDF 78 KB)
-
Familial hypercholesterolaemia: Full guideline (PDF 1.43 MB)
-
-
-
-
-
-
-
-
-
Familial hypercholesterolaemia: Comments proforma (MSWord 41 KB)
-
-
-
-
-
Familial Hypercholesterolaemia: Draft Scope, comments form (MSWord 47 KB)
-